Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DIC Lifetec is a Japan-based, wholly owned subsidiary of DIC focused on commercial health and nutrition products rather than prescription drug development. The company sells spirulina-based dietary supplements, phycocyanin-containing wellness products, and natural blue food colorants marketed under the LINABLUE brand, and it also distributes microalgae-derived DHA oils. Its business appears centered on commercialization of algae-derived ingredients and finished consumer health products, with activities spanning health foods, food additives, cosmetics-related materials, and domestic sales in Japan. DIC Lifetec is part of the broader DIC healthcare/microalgae group, which includes affiliated algae businesses in Japan, the United States, and China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DIC Lifetec.